scispace - formally typeset
J

Janis M. Miyasaki

Researcher at Toronto Western Hospital

Publications -  50
Citations -  11418

Janis M. Miyasaki is an academic researcher from Toronto Western Hospital. The author has contributed to research in topics: Medicine & Parkinson's disease. The author has an hindex of 30, co-authored 39 publications receiving 9786 citations. Previous affiliations of Janis M. Miyasaki include University of Toronto.

Papers
More filters
Journal ArticleDOI

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Christopher G. Goetz, +87 more
- 15 Nov 2008 - 
TL;DR: The combined clinimetric results of this study support the validity of the MDS‐UPDRS for rating PD.
Journal ArticleDOI

Effect of GPi pallidotomy on motor function in Parkinson's disease

TL;DR: In these patients GPi pallidotomy enhanced motor performance, reduced akinesia, improved gait, and eliminated the neural elements responsible for levodopa-induced dyskinesias.
Journal ArticleDOI

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

TL;DR: Initial treatment with pramipexole resulted in lower incidences of freezing, somnolence, and edema and provided for better symptomatic control, as measured by the Unified Parkinson's Disease Rating Scale, compared with initial treatment with levodopa, which resulted in similar quality of life.
Journal ArticleDOI

A controlled trial of rasagiline in early Parkinson disease: The tempo study

Andrew Siderowf, +89 more
- 01 Dec 2002 - 
TL;DR: Rasagiline is effective as monotherapy for patients with early PD and the 2 dosages in this trial were both effective relative to placebo.
Journal ArticleDOI

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

TL;DR: This study describes results of a PET study comparing dopaminergic function during gambling in Parkinson's disease patients, with and without pathological gambling, following dopamine agonists and presents the first evidence of these phenomena in pathological gambling.